Filing Details
- Accession Number:
- 0000899243-22-018604
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-18 16:18:52
- Reporting Period:
- 2022-05-16
- Accepted Time:
- 2022-05-18 16:18:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1847529 | Joy Liu | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-05-16 | 25 | $250.77 | 14,442 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-05-16 | 19 | $251.57 | 14,423 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-05-16 | 20 | $252.49 | 14,403 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-05-16 | 34 | $253.87 | 14,369 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-05-16 | 35 | $254.36 | 14,334 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1.
- Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $250.77 (range $250.00 to $250.90).
- Open market sales reported on this line occurred at a weighted average price of $251.57 (range $251.05 to $251.81).
- Open market sales reported on this line occurred at a weighted average price of $252.49 (range $252.12 to $253.11).
- Open market sales reported on this line occurred at a weighted average price of $253.87 (range $253.14 to $254.13).
- Open market sales reported on this line occurred at a weighted average price of $254.36 (range $254.15 to $254.57).